---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-049755"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T03:00:58.188146+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Passage Bio cuts ~75% of workforce, expects $3.3M in severance costs

## Summary
- Workforce reduction of approximately 75%; substantial completion expected in Q2 and Q3 2026.
- Aggregate severance and exit costs estimated at $3.3 million, primarily recorded in Q2 2026.
- Restructuring part of previously announced strategic alternatives review to maximize shareholder value.
- Severance benefits contingent on execution of release of claims by impacted employees.

## SEC filing metadata
- accession: 0001104659-26-049755
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465926049755/0001104659-26-049755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465926049755/tm2612859d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-049755
- JSON: https://secwatch.observer/filing/0001104659-26-049755.json
- Plain text: https://secwatch.observer/filing/0001104659-26-049755.txt

## Source-grounded claims
- claim_id: dd25d6cba07f2f87385a5e00312c7c85e229d8a2
  claim: Passage BIO, Inc. announced a restructuring with charges of approximately $3.3 million (approximately 75%).
  evidence_excerpt: The Company expects that the aggregate severance and exit costs for the Restructuring Plan will be approximately $3.3 million, which will be recorded primarily in the second quarter of 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465926049755/0001104659-26-049755-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.